BRCA2 and Hereditary breast and ovarian cancer syndrome: Heterozygous BRCA1 and BRCA2 mutations underlying hereditary breast and ovarian cancers (HBOCs) have also been reported to be involved in cellular radiosensitivity and cancer susceptibility.